Lysogorskaya (RU)
{name}
{subtitle}
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~15 mi. (Pyatigorsk, Russia, +201 more cities)
facility
Clinic UZI 4D /ID# 221215
condition
Myelodysplastic Syndromes
drug
azacitidine, +1 more drug
drug type
chemotherapy
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
city
~15 mi. (Pyatigorsk, Russia, +142 more cities)
facility
LLC "Interleykin"
biomarker
del(11)(q10), +27 more biomarkers
condition
Myelofibrosis
drug
imetelstat, +1 more drug
drug type
targeted therapy
A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~15 mi. (Pyatigorsk, Russia, +156 more cities)
facility
LLC Novaya Klinika /ID# 169689
biomarker
IGH-CCND1 Fusion, +1 more biomarker
condition
Multiple Myeloma
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis
city
~15 mi. (Pyatigorsk, Russia, +165 more cities)
facility
Clinic UZI 4D /ID# 221024
biomarker
del(11)(q10), +27 more biomarkers
condition
Myelofibrosis
drug
navitoclax, +1 more drug
drug type
targeted therapy
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
city
~61 mi. (Nalchik, Russia, +127 more cities)
facility
Sbi "City Clinical Hospital №1
biomarker
BRAF V600E
condition
Colorectal Carcinoma
drug
cetuximab, +3 more drugs
drug type
chemotherapy, +1 more type